These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Tissue-culture microtest for predicting response of human cancer to chemotherapy. Holmes HL; Little JM Lancet; 1974 Oct; 2(7887):985-7. PubMed ID: 4138888 [No Abstract] [Full Text] [Related]
64. Chemotherapy in solid tumors of childhood. Lawhorn TI; Stone HH; Martin JD Oncology; 1972; 26(2):250-8. PubMed ID: 4559041 [No Abstract] [Full Text] [Related]
66. [The use of nitrogen mustard in the treatment of lymphatic diseases of a malignant type]. RABENKO J; CORREA URQUIZA LM Prensa Med Argent; 1959 Oct; 46():2549-54. PubMed ID: 14435621 [No Abstract] [Full Text] [Related]
67. Adjuvant chemotherapy for common solid tumors. Berstock DA; Baum M Adv Cancer Res; 1983; 39():315-27. PubMed ID: 6353886 [No Abstract] [Full Text] [Related]
68. NONSURGICAL TREATMENT OF PULMONARY CANCER. KARNOFSKY DA Mod Treat; 1964 Mar; 1():369-78. PubMed ID: 14159593 [No Abstract] [Full Text] [Related]
69. Multiple agent chemotherapy for advanced histiocytic lymphoma. Adler S; Shimaoka K; Han T; Tsukada Y Eur J Cancer (1965); 1976 May; 12(5):395-403. PubMed ID: 60243 [No Abstract] [Full Text] [Related]
71. A comparative study with three alkylating agents: mechlorethamine, cyclophosphamide, and uracil mustard. GOLD GL; SALVIN LG; SHNIDER BI Cancer Chemother Rep; 1962 Feb; 16():417-9. PubMed ID: 13899670 [No Abstract] [Full Text] [Related]
72. Nitrogen mustards in the treatment of neoplastic disease. KARNOFSKY DA Adv Intern Med; 1950; 4():1-75. PubMed ID: 14770961 [No Abstract] [Full Text] [Related]
73. URACIL MUSTARD: A POTENT INDUCER OF LUNG TUMORS IN MICE. ABELL CW; FALK HL; SHIMKIN MB; WEISBURGER EK; WEISBURGER JH; GUBAREFF N Science; 1965 Mar; 147(3664):1443-5. PubMed ID: 14268720 [TBL] [Abstract][Full Text] [Related]
74. [Chemotherapy in the terminal stages of tumors]. Astrakhan VI; Garin AM; Vvedenskaia NA; Bychkov MB Vopr Onkol; 1968; 14(6):92-6. PubMed ID: 4881119 [No Abstract] [Full Text] [Related]
75. [Management of lymphoma with respect to pathologic classification: updates and controversies]. Zhu J; Song YQ Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):724-7. PubMed ID: 20079009 [No Abstract] [Full Text] [Related]
77. Low dosage methotrexate (NSC-740) and cyclophosphamide (NSC 26271) for solid tumors. Foley JF; Lemon HM; Miller D Cancer Chemother Rep; 1970 Feb; 54(1):41-6. PubMed ID: 4334084 [No Abstract] [Full Text] [Related]
78. [A new combination of methotrexate and folinic acid for cancer treatment (acute leukemia and solid tumors)]. Schwarzenberg L; Mathé G; Hayat M; de Vassal F; Amiel JL; Cattan A; Schneider M; Schlumberger JR; Rosenfeld C; Jasmin C; Ngo Minh Man Presse Med (1893); 1969 Mar; 77(11):385-8. PubMed ID: 4891646 [No Abstract] [Full Text] [Related]
79. [Concurrent chemoradiotherapy update]. Reboul F; Vincent P; Chauvet B; Alfonsi M; Berger C; Serin D Bull Cancer; 1999 Jan; 86(1):77-83. PubMed ID: 10029709 [No Abstract] [Full Text] [Related]